In the dynamic landscape of modern medicine, one revolutionary technology is poised to reshape the way we approach diagnostics, treatment, and drug delivery –...
Octave Bioscience, announced the closing of a $30M extension to its Series B funding round. The round included participation from new strategic investors: Novartis (dRx...
The Board of Trustees of SolutionHealth, parent organization of Elliot Health System and Southern New Hampshire Health, has formed a joint venture with Acadia...
Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...
InnoCare Pharma, a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced that BTK inhibitor orelabrutinib has been granted priority review...
